scispace - formally typeset
T

Tatyana Shekhtman

Researcher at University of California, San Diego

Publications -  46
Citations -  1671

Tatyana Shekhtman is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Bipolar disorder & Lithium (medication). The author has an hindex of 15, co-authored 37 publications receiving 1306 citations. Previous affiliations of Tatyana Shekhtman include Mayo Clinic & Veterans Health Administration.

Papers
More filters
Journal ArticleDOI

Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study

Liping Hou, +136 more
- 12 Mar 2016 - 
TL;DR: A genome-wide association study of lithium response in 2,563 patients collected by 22 participating sites from the International Consortium on Lithium Genetics (ConLiGen); the largest attempted so far finds a single locus of four linked SNPs on chromosome 21 met genome- wide significance criteria for association with lithium response.
Journal ArticleDOI

Circadian polymorphisms associated with affective disorders

TL;DR: Findings suggest that perturbations of the circadian gene network at several levels may influence mood disorders, perhaps ultimately through regulation of MAOA and its modulation of dopamine transmission.
Journal ArticleDOI

Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder.

Liping Hou, +148 more
TL;DR: A two-stage meta-analysis of GWAS of bipolar disorder patients and controls revealed genome-wide significant associations at two novel loci, adding to a growing list of common autosomal variants involved in BD and illustrating the power of comparing well-characterized cases to an excess of controls in GWAS.
Journal ArticleDOI

Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study.

Azmeraw T. Amare, +126 more
- 09 Nov 2017 - 
TL;DR: Evidence is provided for a negative association between high genetic loading for SCZ and poor response to lithium in patients with BPAD, suggesting the potential for translational research aimed at personalized prescribing of lithium.